ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

In Brief: NIDDK Begins BPH Trial; Roswell Park Honors Schwarzkopf; NRC Cites MIT

March 1, 1996

The Philadelphia Story: How Surprise Filing by Abramson Spurred Penn to Follow Suit

March 16, 2012

Aspirin Use Associated With Lower Cancer Indicence, Death

April 27, 2007

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

April 15, 2005

Fifty-Nine CCOP Awards Made; Payline 250, Six Funded as Exceptions

May 27, 1983